help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on August 2, 2007, doi:10.1164/rccm.200704-519OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200704-519OCv1
176/8/778    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirakawa, H.
Right arrow Articles by Cataltepe, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirakawa, H.
Right arrow Articles by Cataltepe, S.
American Journal of Respiratory and Critical Care Medicine Vol 176. pp. 778-785, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200704-519OC


Original Article

Cathepsin S Deficiency Confers Protection from Neonatal Hyperoxia-induced Lung Injury

Hiroshi Hirakawa1, Richard A. Pierce2, Gulbin Bingol-Karakoc1, Cagatay Karaaslan1, MeiQian Weng1, Guo-Ping Shi3, Ali Saad4, Ekkehard Weber5, Thomas J. Mariani3, Barry Starcher6, Steve D. Shapiro3 and Sule Cataltepe1

1 Division of Newborn Medicine, Brigham and Women's Hospital and Children's Hospital, Boston, Massachusetts; 2 Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri; 3 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 4 Department of Pathology, Children's Hospital and Harvard Medical School, Boston, Massachusetts; 5 Institute of Physiological Chemistry, Martin Luther University Halle-Wittenberg, Halle, Germany; and 6 Department of Biochemistry, University of Texas, Tyler, Texas

Correspondence and requests for reprints should be addressed to Sule Cataltepe, M.D., Division of Newborn Medicine, Brigham and Women's Hospital, Thorn 1019, 75 Francis Street, Boston, MA 02115. E-mail: scataltepe{at}partners.org

Rationale: Bronchopulmonary dysplasia (BPD) is a chronic lung disease that adversely affects long-term pulmonary function as well as neurodevelopmental outcomes of preterm infants. Elastolytic proteases have been implicated in the pathogenesis of BPD. Cathepsin S (cat S) is a cysteine protease with potent elastolytic activity. Increased levels and activity of cat S have been detected in a baboon model of BPD.

Objectives: To investigate whether deficiency of cat S alters the course of hyperoxia-induced neonatal lung injury in mice.

Methods: Newborn wild-type and cat S–deficient mice were exposed to 80% oxygen for 14 days. Histologic and morphometric analysis were performed and bronchoalveolar lavage protein and cells were analyzed. Lung elastin was assessed by real-time polymerase chain reaction, in situ hybridization, desmosine analysis, and Hart's stain. Distribution of myofibroblasts was analyzed by immunofluorescence. Hydroxyproline content of lung tissues was measured.

Measurements and Main Results: Hyperoxia-exposed cat S–deficient mice were protected from growth restriction and had improved alveolarization, decreased septal wall thickness, lower number of macrophages, and lower protein concentration in bronchoalveolar lavage fluid. {alpha}-Smooth muscle actin–expressing myofibroblasts accounted for at least some of the increased interstitial cellularity in hyperoxia-exposed mouse lungs and were significantly less in cat S–deficient lungs. Lung hydroxyproline content was increased in hyperoxia-exposed wild-type, but not in cat S–deficient lungs. Desmosine content was significantly reduced in both genotypes with hyperoxia.

Conclusions: Cathepsin S deficiency improves alveolarization, and attenuates macrophage influx and fibroproliferative changes in hyperoxia-induced neonatal mouse lung injury.

Key Words: cathepsin • bronchopulmonary dysplasia • hyperoxia • myofibroblast


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Cathepsin S is a lysosomal papain-like cysteine protease with elastolytic activity. Limited information is available on the in vivo role of cathepsin S in normal or diseased lung, particularly in relationship to the alterations in extracellular matrix.

What This Study Adds to the Field
Deficiency of cathepsin S protected newborn mice from hyperoxia-induced growth restriction, impaired alveolarization, fibroproliferation, and macrophage influx. These improvements were not accompanied by any differences in lung elastin content.

 



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
R. A. Fowler, N. K. J. Adhikari, D. C. Scales, W. L. Lee, and G. D. Rubenfeld
Update in Critical Care 2007
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 808 - 819.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society
  ATS State of the Art Course 2008